23 Feb MEDIPOST America

Antonio Lee, Ph.D., CEO and Global Head, Business Development
Pangyo, South Korea
(KOSDAQ: 078160)
MEDIPOST operates the largest private cord blood bank CELLTREE® in South Korea with over 255,000 units of private cord blood bank under storage. Each year, over 20,000 private cord blood units are collected and stored at CELLTREE®. MEDIPOST’s research and development is focused on novel off-the-shelf, allogeneic cell therapeutics using human Umbilical Cord Blood-derived Mesenchymal Stromal Cells (hUCB-MSCs) with clinical-stage assets in the disease areas of osteoarthritis (OA), broncho-pulmonary dysplasia (BPD) and Alzheimer’s disease (AD). Preclinical-stage pipeline includes alopecia and diabetic nephropathy. MEDIPOST America Inc. is wholly-owned subsidiary of MEDIPOST with commercial and development rights for the Americas and Europe. www.medi-post.com